Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Discovery & Translation

Science Spotlight: Cancer prognosis via deep learning, new protein degraders, and more

BioCentury’s roundup of translational innovations

September 19, 2024 12:22 AM UTC
Updated on Sep 24, 2024 at 12:01 AM UTC

A pair of publications in Science and Nature highlight continued progress in deep learning methods for cancer diagnosis and prognosis, in one case by linking non-coding mutations to changes in gene regulation and in the other by further improving histopathology assessment.

In the first study, published in Science, a group at Stanford, in collaboration with Illumina Inc. (NASDAQ:ILMN), Nvidia Corp. (NASDAQ:NVDA) and The Cancer Genome Atlas Analysis Network, aim to identify changes in the regulatory networks that control chromatin accessibility, and thereby gene expression, in cancer cells with non-coding mutations. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article